Current market catalysts

Intuitive Surgical Exec Says Planned 2027 Extended-Use Instrument Program Could Provide Tailwind To Procedure Growth As Investors Weigh Slowing U.S. Growth; Bariatrics Is Just Over 2% Of Global da Vinci Procedures, With Its Incremental Impact Moderating Over Time

SuperX AI Technology shares are trading higher after the company announced its buyback update.

Stock of the Day: Is this the Bottom for Axon?

Axon shares find support at the key $505 level, potentially signaling a reversal higher as recurring buying and selling makes it pivotal.

Chime Stock Rises on Raised Guidance, Plans to Acquire Its Bank Partner

Chime Financial shares are rising after the company announced it expects a year-over-year increase in its Q3 and FY26 revenue guidance.

Mission Produce shares are trading higher after the company reported better-than-expected Q3 sales results.

Barclays Maintains Overweight on Smithfield Foods, Lowers Price Target to $29

These Analysts Revise Their Forecasts On Braze Following Upbeat Q2 Results

Braze beat Q2 estimates and raised FY2027 guidance, but shares fell 13.7%; analysts lifted or maintained price targets.

Barclays Maintains Overweight on Ionis Pharmaceuticals, Lowers Price Target to $85

Guggenheim Maintains Buy on IDEAYA Biosciences, Raises Price Target to $57

Reported September 8, 'Justice Department to take a closer look at Fox’s $22 billion Roku deal' - Semafor Exclusive

Barclays Maintains Overweight on Chime Financial, Raises Price Target to $40

Wellchange Holdings shares are trading lower. The company's 1-for-5 reverse stock split went into effect yesterday.

Bernie Sanders Slams Big Tech as AI Industry Spends $300 Million to Crush Tougher Regulation — ‘81% of Americans’ Say Congress Isn’t Doing Enough

Sanders says the AI industry’s $300M political spending undermines support for stronger regulation and urges Congress to resist Big Tech.

ODDITY Tech Q2 2026 Earnings Call Transcript

ODDITY Tech (NASDAQ:ODD) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcripts and financial

Barclays Upgrades Sagimet Biosciences to Overweight, Raises Price Target to $18

Leading And Lagging Sectors For September 9, 2026

Gainers Symbol Name Price Change ($) Change (%) Volume (NYSE:XLE) State Street Energy Select Sector SPDR ETF 65.4400 0.67 1.03 330.5K (NYSE:XLC) State Street Communication Services Select Sector SPDR

BioMarin Says Phase 3 Study Of VOXZOGO In Hypochondroplasia Met Primary Endpoint With 2.33 cm/Year Improvement In Annualized Growth Velocity vs. Placebo At 52 Weeks; Says sNDA Submitted To FDA

Raytech Holding To Rebrand As Atlas Trinity Tech, Begins Trading Under New Ticker “ATTT” On September 10

How To Earn $500 A Month From American Eagle Stock Ahead Of Q2 Earnings

American Eagle expects Q2 EPS of 22¢ and revenue of $1.37B; 12,000 shares could generate $500 monthly in dividends.

Citizens Maintains Market Outperform on Pharvaris, Raises Price Target to $79

Genasys Receives New $3M Long Range Acoustic Device Orders From U.S., Other Nations

Gossamer Bio Announces 1-For-80 Reverse Stock Split, Effective September 10

8-K filing — Limbach Holdings, Inc. (LMB)

Filed: 2026-09-09 AccNo: 0001628280-26-061042 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 1.02: Termination of a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: Financial Statements and Exhibits

BMO Capital Downgrades Westlake to Market Perform, Lowers Price Target to $82

Megan Holdings Announces 1-For-30 Share Consolidation Effective September 17, Superseding Prior 1-For-40 Plan

Citizens Reiterates Market Outperform on Oracle, Maintains $285 Price Target

SANGRIX Sells Aggregate Of 3M Dogecoin, Generating ~$267,665 In Gross Proceeds To Support Working Capital And Transition Toward AI Computing Infrastructure

Uni-Fuels Holdings Raises FY2026 Sales Guidance from $320.000M-$340.000M to $340.000M-$360.000M vs $332.494M Est

BMO Capital Initiates Coverage On Steven Madden with Outperform Rating, Announces Price Target of $60

Imax To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Wednesday

Analysts cut targets for CAN, TTAN and BSX, while raising targets for BRZE, VRNS, IMAX, PHVS and CHYM. Ratings largely remained positive.